Rising popularity of GLP-1 therapies Obesity affects about 40 % of American adults
Available at: Akbari, H., Elyasi, L., Khaleghi, A
clinician determines final eligibility Who shouldn't apply: Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, certain severe GI or kidney conditions, pregnancy, or breastfeeding - clinician screens at intake FDA regulatory status as of June 2026: Active enforcement and regulatory change ongoing
older adults make sense to me
When to seek medical help : Contact your GP if you experience persistent gastrointestinal symptoms, signs of hypoglycaemia (shakiness, confusion, sweating), unusual bleeding or bruising, or any concerning symptoms after starting these supplements